Provided by Tiger Trade Technology Pte. Ltd.

Cardiff Oncology, Inc.

0.8801
-0.0286-3.15%
Post-market: 0.90700.0269+3.05%19:44 EDT
Volume:653.49K
Turnover:592.10K
Market Cap:68.36M
PE:-1.49
High:0.9289
Open:0.9266
Low:0.8800
Close:0.9087
52wk High:3.31
52wk Low:0.7566
Shares:77.67M
Float Shares:75.24M
Volume Ratio:1.17
T/O Rate:0.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5914
EPS(LYR):-0.6863
ROE:-94.08%
ROA:-46.73%
PB:2.58
PE(LYR):-1.28

Loading ...

Cardiff Oncology Announces Special Shareholder Meeting

Reuters
·
Aug 15

Replimune Q1 Net Loss Narrows as Expenses Decline

Reuters
·
Aug 14

Elicio Therapeutics Q2 Net Loss Narrows as R&D Expenses Fall

Reuters
·
Aug 14

PDS Biotechnology Q2 Net Loss Widens Slightly as Operating Costs Fall

Reuters
·
Aug 13

Pyxis Oncology Q2 Loss Widens on Increased Administrative Costs

Reuters
·
Aug 13

William Blair Downgrades Cardiff Oncology to Market Perform From Outperform

MT Newswires Live
·
Aug 12

Cardiff Oncology, Inc. : William Blair Cuts to Market Perform Rating

THOMSON REUTERS
·
Aug 12

Analysts Offer Insights on Healthcare Companies: Neurogene (NGNE) and Cardiff Oncology (CRDF)

TIPRANKS
·
Aug 12

William Blair downgrades Cardiff Oncology (CRDF) to a Hold

TIPRANKS
·
Aug 12

Cardiff Oncology Q2 EPS $(0.14) Beats $(0.16) Estimate, Sales $104.000K Beat $70.714K Estimate

Benzinga Earnings
·
Aug 12

Cardiff Oncology Q2 Operating Expenses Fall on Lower R&D Costs

Reuters
·
Aug 12

Cardiff Oncology Q2 Operating Expenses USD 9.719 Million

THOMSON REUTERS
·
Aug 12

Cardiff Oncology Q2 EPS USD -0.14

THOMSON REUTERS
·
Aug 12

Cardiff Oncology Gugat Nerviano Atas Sengketa Lisensi Onvansertib

Reuters
·
Aug 12

Cardiff Oncology Rugi Bersih FY26 Kuartal II Menyempit Menjadi USD 21,6 Juta; Revenue Tetap USD 0,1 Juta

Reuters
·
Aug 12

Cardiff Oncology Inc Expected to Post a Loss of 16 Cents a Share - Earnings Preview

Reuters
·
Jul 25

Cardiff Oncology CEO Mani Mohindru Acquires 34,364 Shares Worth $50,002.62

Reuters
·
Jul 17

Cardiff Oncology Issues Warrants to Buy 9,303,136 Shares in Registered Direct Offering

Reuters
·
Jul 15

Cardiff Oncology Announces $10 Million Registered Direct Offering

THOMSON REUTERS
·
Jul 15

Cardiff Oncology CEO Mani Mohindru acquires 24,703 common shares for $29,890.63

Reuters
·
Jun 22